[Form 4] Lineage, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lineage, Inc. (LINE) officer Sudarsan V. Thattai reported a purchase of 3,563 shares of Lineage common stock on 08/08/2025 at a weighted-average price of $42.4469, bringing his beneficial ownership to 7,983 shares directly. The Form 4 discloses the price range for the purchases was $42.4450 to $42.4796.

The filing lists Mr. Thattai as Chief Information Officer and Chief Transformation Officer. A footnote says the reporting person will provide share-by-share pricing details on request; no derivative transactions or 10b5-1 plan indication are shown in the provided content.

Positive

• Officer acquisition disclosed: Sudarsan V. Thattai purchased 3,563 shares of Lineage common stock.
• Increased direct ownership: Beneficial ownership rose to 7,983 shares following the reported transaction.
• Price transparency: Filing reports a weighted-average price of $42.4469 and discloses a purchase price range of $42.4450–$42.4796.

Negative

• None.

Insights

Securities Analyst

TL;DR: An officer purchase of 3,563 LINE shares at a weighted ~$42.45 increases direct ownership to 7,983 shares; transaction disclosed via Form 4.

The purchase is a straightforward insider acquisition disclosed under Section 16. Insider purchases can signal confidence by management, and the filing provides a weighted-average price plus a disclosed price range of $42.4450–$42.4796. The transaction was reported as a direct acquisition of common stock with no accompanying derivative activity listed. Given the limited size information available relative to total outstanding shares, treat this as a routine insider buy disclosure rather than a materially transformative event.

Corporate Governance Expert

TL;DR: Form 4 shows compliant disclosure of an officer purchase; footnote offers additional pricing transparency upon request.

The filing names the reporting person and his officer roles and reports a purchase (transaction code P) with a weighted-average price and explicit price range footnote, which supports transparency. The Form appears filed by a single reporting person and signed by an attorney-in-fact, consistent with common practice. The document does not indicate that the trade was executed under a 10b5-1 plan, and no derivative positions or dispositions are reported. From a governance perspective, this is a routine, properly documented insider purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thattai Sudarsan V

(Last) (First) (Middle)

C/O LINEAGE, INC.

46500 HUMBOLDT DRIVE

(Street)

NOVI MI 48377

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lineage, Inc. [ LINE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		P		3,563	A	$42.4469(1)	7,983	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in transactions at prices ranging from $42.4450 to $42.4796, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

Chief Information Officer and Chief Transformation Officer

	/s/ Brian Golper, as Attorney-in-Fact for Sudarsan V Thattai	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Lineage insider Sudarsan V. Thattai report (LINE)?

The Form 4 reports a purchase of 3,563 shares of Lineage common stock on 08/08/2025, increasing his beneficial ownership to 7,983 shares.

At what price were the LINE shares purchased?

The filing shows a weighted-average purchase price of $42.4469, with a disclosed price range of $42.4450 to $42.4796.

What is Sudarsan Thattai's role at Lineage (LINE)?

The Form 4 remarks list him as Chief Information Officer and Chief Transformation Officer.

Does the filing show any derivative transactions or a 10b5-1 plan?

No derivative securities are reported in the provided Table II, and the content does not indicate that the transaction was executed under a 10b5-1 plan.

Who signed the Form 4 for Sudarsan Thattai?

The form is signed by /s/ Brian Golper, as Attorney-in-Fact for Sudarsan V. Thattai (signature date shown as 08/11/2025 in the filing).